RE: Just my opinion!12 Oct 2023 08:55
FTM, you say the share price has barely budged in the last 10 years. Well in the last five it has been anywhere between 10p -to 80p. That's not a share price that has "barely budged". Of course, you may have bought in at higher prices (I started there).
I have always considered this to be a long-term investment (for me that is 10 years+). I first bought in 2021 so I have a long way to go. But the reason I highlight 2027/28 is that, by then, there will be a nine-figure capacity (over £150m, perhaps £250m?) and crucially by then SCE will have multiple contracts being supplied and paying at the same time. Until that capacity is built there will remain significant restraints on revenue.
Any reader of these pages (or ADVFN for that matter) will hear you frequently complain about the management (capital raises, content of RNSs etc). I am not here to defend the management and I would agree there have been a few mis-steps along the way. But I feel you're overly critical of them. The installation and commissioning of the new furnaces is something that has not been done before. The fact it went slightly askew and required about £2.5m (is that correct?) to fix them is not unexpected. But they have put that right and, crucially, own the "interlectual knowledge" about how to fix them. I view the complexity of producing this stuff as a benefit (a Buffett moat).
I acknowledge the fact that Kevin Johnson, David Bundred etc have designed a fabulous product against a monopolistic supplier. That product is aligned with the future of motoring (lighter, greener, more suitable to EVs etc) in a market that will only get bigger as CCB start appearing on non-supercars. They have hooked some major fish already. The new board members and NEDs have some impressive credentials and I would also give David Bundred/ Kevin Johnson some credit for realising the need for them when it is always easy to cling on yourself.
You're correct that the company is not "new", but it is still young in its growth trajectory. That might be the result of a preference to grow slowly and deliberately without basically going for broke too early on.
I repeat that this is a company with 60% gross margins with a market leading product and only one competitor. Nothing is certain but that is a great investment opportunity for the patient.